Discovery of S -Nitrosoglutathione Reductase Inhibitors: Potential Agents for the Treatment of Asthma and Other Inflammatory Diseases
about
S-nitrosoglutathione reductases are low-copy number, cysteine-rich proteins in plants that control multiple developmental and defense responses in Arabidopsis.ADH IB expression, but not ADH III, is decreased in human lung cancer.Proteomic characterization of the cellular response to nitrosative stress mediated by s-nitrosoglutathione reductase inhibition.NOS1-derived nitric oxide promotes NF-κB transcriptional activity through inhibition of suppressor of cytokine signaling-1.Protein S-Nitrosylation as a Therapeutic Target for Neurodegenerative Diseases.Mechanisms of S-nitrosothiol formation and selectivity in nitric oxide signaling.Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation.Augmentation of S-Nitrosoglutathione Controls Cigarette Smoke-Induced Inflammatory-Oxidative Stress and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis by Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function.The latest advances in the discovery of nitric oxide hybrid drug compounds.Pharmacological inhibition of S-nitrosoglutathione reductase improves endothelial vasodilatory function in rats in vivo.S-Nitrosoglutathione Reductase Underlies the Dysfunctional Relaxation to Nitric Oxide in Preterm Labor.
P2860
Q33356943-437C5277-1EF8-4839-B76D-F381C70467F8Q34534948-87DA5E7A-00F5-4FF4-9C7E-F53CBB50E953Q35890903-0A2B4677-652A-41B0-9E44-A91FF167529BQ36080679-DEEBA46B-9304-40BA-B7A0-6C7DF645EC19Q36421954-6508352A-F4F8-4ED7-A599-52FB861A13E6Q36456739-71B140A5-4025-4072-AA8C-D437D61CB0A5Q37484903-1E079F69-7F53-410A-B1FA-D57C0E7AA95EQ39071592-B6690259-36A2-49A6-A730-E43111B38298Q39406582-93627A0A-92A6-4043-B7FD-AEEDA2A46E9DQ39558562-AB86038A-B9C4-4F00-AEBF-D69DB78E1523Q52606347-15F9CABE-4842-4807-9D09-854FEF49FB4A
P2860
Discovery of S -Nitrosoglutathione Reductase Inhibitors: Potential Agents for the Treatment of Asthma and Other Inflammatory Diseases
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Discovery of S -Nitrosoglutath ...... nd Other Inflammatory Diseases
@ast
Discovery of S -Nitrosoglutath ...... nd Other Inflammatory Diseases
@en
Discovery of S -Nitrosoglutath ...... nd Other Inflammatory Diseases
@nl
type
label
Discovery of S -Nitrosoglutath ...... nd Other Inflammatory Diseases
@ast
Discovery of S -Nitrosoglutath ...... nd Other Inflammatory Diseases
@en
Discovery of S -Nitrosoglutath ...... nd Other Inflammatory Diseases
@nl
prefLabel
Discovery of S -Nitrosoglutath ...... nd Other Inflammatory Diseases
@ast
Discovery of S -Nitrosoglutath ...... nd Other Inflammatory Diseases
@en
Discovery of S -Nitrosoglutath ...... nd Other Inflammatory Diseases
@nl
P2093
P2860
P921
P356
P1476
Discovery of S -Nitrosoglutath ...... nd Other Inflammatory Diseases
@en
P2093
Adam M Stout
Dorothy B Colagiovanni
Gary J Rosenthal
Jan W F Wasley
Jane P Richards
Joan P Blonder
Lawrence Chun
Louis S Green
Sarah A Strong
P2860
P356
10.1021/ML200045S
P577
2011-05-12T00:00:00Z